Fidelity Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $351M | Sell |
|
|||||
|
2024
Q4 | $925M | Sell |
|
|||||
|
2024
Q3 | $814M | Sell |
|
|||||
|
2024
Q2 | $770M | Buy |
|
|||||
|
2024
Q1 | $775M | Sell |
|
|||||
|
2023
Q4 | $821M | Buy |
|
|||||
|
2023
Q3 | $572M | Sell |
|
|||||
|
2023
Q2 | $708M | Sell |
|
|||||
|
2023
Q1 | $647M | Sell |
|
|||||
|
2022
Q4 | $637M | Buy |
|
|||||
|
2022
Q3 | $478M | Sell |
|
|||||
|
2022
Q2 | $590M | Sell |
|
|||||
|
2022
Q1 | $670M | Sell |
|
|||||
|
2021
Q4 | $574M | Sell |
|
|||||
|
2021
Q3 | $413M | Sell |
|
|||||
|
2021
Q2 | $495M | Sell |
|
|||||
|
2021
Q1 | $412M | Buy |
|
|||||
|
2020
Q4 | $382M | Buy |
|
|||||
|
2020
Q3 | $304M | Buy |
|
|||||
|
2020
Q2 | $219M | Buy |
|
|||||
|
2020
Q1 | $119M | Buy |
|
|||||
|
2019
Q4 | $217M | Buy |
|
|||||
|
2019
Q3 | $45.8M | Sell |
|
|||||
|
2019
Q2 | $107M | Buy |
|
|||||
|
2019
Q1 | $101M | Buy |
|
|||||
|
2018
Q4 | $93.5M | Buy |
|
|||||
|
2018
Q3 | $178M | Buy |
|
|||||
|
2018
Q2 | $145M | Buy |
|
|||||
|
2018
Q1 | $173M | Buy |
|
|||||
|
2017
Q4 | $119M | Buy |
|
|||||
|
2017
Q3 | $126M | Buy |
|
|||||
|
2017
Q2 | $80.9M | Buy |
|
|||||
|
2017
Q1 | $106M | Buy |
|
|||||
|
2016
Q4 | $97.9M | Buy |
|
|||||
|
2016
Q3 | $98.9M | Buy |
|
|||||
|
2016
Q2 | $252M | Buy |
|
|||||
|
2016
Q1 | $180M | Buy |
|
|||||
|
2015
Q4 | $347M | Buy |
|
|||||
|
2015
Q3 | $252M | Buy |
|
|||||
|
2015
Q2 | $168M | Buy |
|
|||||
|
2015
Q1 | $125M | Buy |
|
|||||
|
2014
Q4 | $77.8M | Buy |
|
|||||
|
2014
Q3 | $60.4M | Buy |
|
|||||
|
2014
Q2 | $73.9M | Buy |
|
|||||
|
2014
Q1 | $79.7M | Buy |
|